solution-phase chemistry became very complex, discouraging
us from expanding the solid-phase chemistry in this direction.
In conclusion, we have developed a novel benzylamine
resin (4-benzyloxy-2-methoxybenzylamine, BOMBA)10 on
which a de novo solid-phase synthesis11 of disubstituted
1,2,4-triazoles was successfully demonstrated. To the best
of our knowledge, this is the first reported synthesis of 1,2,4-
triazoles entailing tethering of the nascent heterocycle to the
resin through a ring nitrogen, thereby permitting a “traceless”
synthesis. The construction of heterocycles on solid phase
via linkage directly to the ring has proven in general to be
a valuable strategy because it permits facile variation of
substituents.12 The overall yields and purities realized in the
production of a 96-member library suggest that the chemistry
is sufficiently general to accommodate a variety of substit-
uents, although clearly diversity would be expected to be
tolerated to the greatest degree in the nucleophilic addition
step. It is worth noting that the success of this synthetic route
was greatly facilitated by the IRORI AccuTag technology,13
which is able to conveniently accommodate the introduction
of diversity early in a synthetic sequence.
(11) Procedures for the Solid-Phase Synthesis of 5-(4-Chlorophenyl)-
3-{[(4-chlorophenyl)thio]methyl}-1H-1,2,4-triazole (13a) from Resin 6b.
Six IRORI MiniKans, filled with BOMBA resin 6b (60 mg in each), were
placed in a 100-mL round-bottom flask, to which were added CH2Cl2 (30
mL) and triethylamine (2.09 mL, 15.0 mmol). The MiniKans were degassed.
After cooling to 0 °C, 4-chlorobenzoyl chloride (1.90 mL, 15.0 mmol) was
added and the MiniKans were stirred at 0 °C for an additional 30 min.
Once warmed to room temperature, the MiniKans were stirred for another
6 h. The reaction solution was then decanted off, and the MiniKans were
washed with CH2Cl2 and MeOH (alternating, three wash cycles). Following
a final wash with pyridine, the MiniKans containing resin 7b were dried in
vacuo. To a solution of Lawesson’s reagent (1.60 g, 3.96 mmol) in pyridine
(25 mL) was added 7b. The MiniKans were degassed, and the reaction
mixture was heated to 85 °C. After heating for 24 h, the reaction solution
was decanted, and the MiniKans were washed with CH2Cl2 and MeOH
(three alternating cycles). After a final wash with pyridine, the MiniKans
were resubjected to the reaction conditions for an additional 24 h. Once
again the reaction solution was decanted, and the MiniKans were washed
with 1:1 pyridine/H2O, followed by CH2Cl2 and MeOH (three alternating
cycles). After a final CH2Cl2 wash, the MiniKans were dried in vacuo. To
the six IRORI MiniKans, now containing thioamide resin 8b, in a 100 mL
round-bottom flask was added CH2Cl2 (20 mL). The mixture was degassed
before the addition of methyl triflate (0.907 mL, 8.00 mmol). After agitating
overnight at room temperature, the reaction solution was decanted, and the
MiniKans were washed with CH2Cl2 and acetonitrile (alternating, three
cycles). After a final wash with 2-methoxyethanol in preparation for the
next step, the MiniKans were dried in vacuo. The MiniKans containing
thioimidate resin were submersed in 2-methoxyethanol (25 mL), degassed,
and mechanically agitated for 10 min before hydrazine monohydrate (1.21
mL, 25.0 mmol) was added. After agitating for 24 h at room temperature,
the reaction solution was decanted, and the MiniKans were washed with
CH2Cl2 and acetonitrile (three alternating wash cycles). After a final wash
with 2-methoxyethanol, the MiniKans were resubjected to the reaction
conditions for an additional 24 h. The reaction solution was again decanted,
and the MiniKans were washed with CH2Cl2 and acetonitrile (alternating,
three cycles). After the final wash with CH2Cl2, the MiniKans were dried
in vacuo. To the MiniKans containing amidrazone resin 9b was added
CH2Cl2 (25 mL). The mixture was degassed before the addition of
chloroacetyl chloride (2.00 mL, 25.0 mmol). After the reaction was capped
and mechanically shaken at room temperature for 24 h, the reaction solution
was decanted, and the MiniKans were washed with CH2Cl2 and MeOH
(three alternating cycles). Finally, the MiniKans were washed with DMF
and dried in vacuo. Acylated resin 10b, in IRORI MiniKans, was submersed
in 1:1 DMF/AcOH (30 mL), degassed, and mechanically agitated at room
temperature for 20 h. The reaction solution was decanted, and the MiniKans
were washed with CH2Cl2 and MeOH (alternating, three wash cycles). The
MiniKans were dried in vacuo. A small sample of the resin was then cleaved
with 10% TFA in CH2Cl2. HPLC/MS analysis at this step indicated a purity
Supporting Information Available: Full experimental
details for the solution-phase synthesis of 13a from 6a,
including analytical and spectroscopic data for each inter-
mediate, and procedures for the synthesis of the 96-member
triazole library with the IRORI AccuTag-100 system. This
material is available free of charge via the Internet at http://
pubs.acs.org. This material is available free of charge via
OL016578A
of 96% at 254 nm and 87% at 210 nm. In a 50-mL round-bottom flask,
potassium hydroxide (1.68 g, 30 mmol) was dissolved in 1:1 THF/2-
methoxyethanol (30 mL). After the solution was degassed, 4-chlorothiophe-
nol (4.34 g, 30 mmol) was added, and the solution was stirred for 10 min.
Triazole resin 11b, in IRORI MiniKans, was added, and the reaction mixture
was once again degassed. After stirring at room temperature for 24 h, the
reaction solution was decanted, and the MiniKans were washed with CH2Cl2
and MeOH (three alternating wash cycles). After drying in vacuo, one of
the MiniKans, originally loaded with 60 mg of resin 6b, was cleaved with
10% TFA/CH2Cl2 (rt, 1 h), affording 5.7 mg of 13a (65% overall yield
from 6b). Purity of the final product was 89% at 254 nm, and 78% at 210
1
nm. H NMR (300 MHz, CDCl3) δ 4.28 (s, 2 H), 7.26 (d, J ) 8.1 Hz, 2
H), 7.31 (d, J ) 8.5 Hz, 2 H), 7.43 (d, J ) 8.3 Hz, 2 H), 7.95 (d, J ) 8.4
Hz, 2 H). 13C NMR (100 MHz, DMSO-d6) δ 28.87, 126.58, 127.94, 128.75,
129.28, 129.36, 129.54, 130.56, 131.27, 134.48, 134.77. MS (ES+) m/z
336 (100), 338 (72).
(12) (a) Backes, B. J.; Ellman, J. A. Curr. Opin. Chem. Biol. 1997, 1,
86-93. (b) For a recent review on solid-phase heterocycle syntheses, see:
Franzen, R. G. J. Combi. Chem. 2000, 2, 195-214.
(13) Mendonca, A. J. Am. Lab. 1998, 30, 46-47.
3344
Org. Lett., Vol. 3, No. 21, 2001